VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 52 filers reported holding VOR BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $9,094 | -34.8% | 3,837 | -38.1% | 0.00% | – |
| Q4 2023 | $13,952 | -20.8% | 6,201 | -25.4% | 0.00% | – |
| Q3 2023 | $17,624 | -54.5% | 8,313 | -33.7% | 0.00% | – |
| Q2 2023 | $38,727 | -22.5% | 12,533 | +52.5% | 0.00% | – |
| Q1 2022 | $50,000 | -58.0% | 8,221 | -19.8% | 0.00% | – |
| Q4 2021 | $119,000 | -26.1% | 10,252 | 0.0% | 0.00% | – |
| Q3 2021 | $161,000 | -45.2% | 10,252 | -34.9% | 0.00% | – |
| Q2 2021 | $294,000 | -60.4% | 15,746 | -8.5% | 0.00% | -100.0% |
| Q1 2021 | $742,000 | – | 17,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $124,814,000 | 31.41% |
| Trustees of Columbia University in the City of New York | 183,821 | $3,428,000 | 5.06% |
| RA Capital Management | 11,120,973 | $207,406,000 | 3.33% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $20,042,000 | 2.05% |
| Sarissa Capital Management LP | 707,010 | $13,186,000 | 1.05% |
| SECTORAL ASSET MANAGEMENT INC | 405,324 | $7,559,000 | 0.61% |
| Woodline Partners LP | 1,146,494 | $21,382,000 | 0.40% |
| Artal Group S.A. | 550,000 | $10,258,000 | 0.21% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 50,000 | $933,000 | 0.20% |
| Orbimed Advisors | 833,333 | $15,542,000 | 0.16% |